[PROVISIONAL] Humoral immune response in adult Brazilian patients with Mucolipidosis III gamma
Abstract Mucolipidosis II and III (ML II and III) alpha/beta and ML III gamma are lysosomal diseases caused by GlcNAc-1-phosphotransferase deficiency. Previous data indicate that MLII patients have a functionally impaired immune system that contributes to the high predisposition to infections. We ev...
Main Authors: | Fernanda Sperb-Ludwig, Taciane Alegra, Renata Voltolini Velho, Nataniel Ludwig, Marina Siebert, Mariana Jobim, Filippo Vairo, Ida V. D. Schwartz |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Genética
|
Series: | Genetics and Molecular Biology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572019005022104&lng=en&tlng=en |
Similar Items
-
In vitro substrate reduction, chaperone and immunomodulation treatments reduce heparan sulfate in mucolipidosis III human fibroblasts
by: Fernanda Sperb-Ludwig, et al.
Published: (2023-12-01) -
A decade of molecular diagnosis of Mucolipidosis II and III in Brazil: a pooled analysis of 32 patients
by: Nataniel F Ludwig, et al.
Published: (2021-04-01) -
Next-generation sequencing corroborates a probable de novo GNPTG variation previously detected by Sanger sequencing
by: Nataniel Floriano Ludwig, et al.
Published: (2017-06-01) -
Mucolipidosis III
by: Ibis Menéndez Alejo, et al.
Published: (1995-08-01) -
Exome sequencing for mucolipidosis III: Detection of a novel GNPTAB gene mutation in a patient with a very mild phenotype
by: F. Sperb-Ludwig, et al.
Published: (2015-03-01)